Lensar Inc Stock Today

LNSR Stock  USD 15.13  0.53  3.63%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
LENSAR is selling at 15.13 as of the 17th of March 2025; that is 3.63 percent increase since the beginning of the trading day. The stock's lowest day price was 14.6. LENSAR has less than a 14 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
2nd of October 2020
Category
Healthcare
Classification
Health Care
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida. The company has 11.79 M outstanding shares of which 63.32 K shares are now shorted by private and institutional investors with about 1.0 trading days to cover. More on LENSAR Inc

Moving together with LENSAR Stock

  0.74BAX Baxter InternationalPairCorr

Moving against LENSAR Stock

  0.92SRDX SurModicsPairCorr
  0.85SMLR Semler ScientificPairCorr
  0.84TELA Tela Bio Earnings Call This WeekPairCorr
  0.81INFU InfuSystems HoldingsPairCorr
  0.79EMBC Embecta CorpPairCorr
  0.61WST West PharmaceuticalPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

LENSAR Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO PresidentNicholas Curtis
Thematic IdeaDrugs (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.730.8069
Moderately Down
Slightly volatile
Gross Profit Margin0.390.4833
Significantly Down
Slightly volatile
Total Current Liabilities11.1 M15 M
Way Down
Slightly volatile
Non Current Liabilities Total34.3 M32.6 M
Sufficiently Up
Slightly volatile
Total Assets68.2 M66.3 M
Fairly Up
Slightly volatile
Total Current Assets40 M42 M
Notably Down
Slightly volatile
Debt Levels
LENSAR can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LENSAR's financial leverage. It provides some insight into what part of LENSAR's total assets is financed by creditors.
Liquidity
LENSAR Inc currently holds 2.61 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. LENSAR Inc has a current ratio of 3.08, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about LENSAR's use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

(2.39 Million)
LENSAR Inc (LNSR) is traded on NASDAQ Exchange in USA. It is located in 2800 Discovery Drive, Orlando, FL, United States, 32826 and employs 140 people. LENSAR is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 178.38 M. LENSAR Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 11.79 M outstanding shares of which 63.32 K shares are now shorted by private and institutional investors with about 1.0 trading days to cover. LENSAR Inc currently holds about 25.2 M in cash with (2.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.29.
Check LENSAR Probability Of Bankruptcy
Ownership Allocation
The market capitalization of LENSAR Inc is $178.38 Million. LENSAR Inc holds substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check LENSAR Ownership Details

LENSAR Stock Institutional Holders

InstituionRecorded OnShares
Essex Investment Management Company, Llc2024-12-31
39.9 K
State Street Corp2024-12-31
39.4 K
Bank Of America Corp2024-12-31
27.7 K
Atria Investments Llc
26.1 K
Bailard Inc2024-12-31
20.3 K
Northern Trust Corp2024-12-31
20 K
Sanctuary Advisors, Llc2024-12-31
19.5 K
Evernest Financial Advisors Llc2024-12-31
19.5 K
Nuveen Asset Management, Llc2024-12-31
17.9 K
Park West Asset Management Llc2024-12-31
810.7 K
Dimensional Fund Advisors, Inc.2024-12-31
614.4 K
View LENSAR Diagnostics

LENSAR Historical Income Statement

At this time, LENSAR's Income Tax Expense is relatively stable compared to the past year. As of 03/17/2025, Depreciation And Amortization is likely to grow to about 4 M, while EBIT is likely to drop (10.4 M). View More Fundamentals

LENSAR Stock Against Markets

LENSAR Corporate Executives

Elected by the shareholders, the LENSAR's board of directors comprises two types of representatives: LENSAR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LENSAR. The board's role is to monitor LENSAR's management team and ensure that shareholders' interests are well served. LENSAR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LENSAR's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA IICFO SecretaryProfile

Additional Tools for LENSAR Stock Analysis

When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.